Unknown

Dataset Information

Quality Control of Widely Used Therapeutic Recombinant Proteins by a Novel Real-Time PCR Approach.


ABSTRACT:

Background

Existence of bacterial host-cell DNA contamination in biopharmaceutical products is a potential risk factor for patients receiving these drugs. Hence, the quantity of contamination must be controlled under the regulatory standards. Although different methods such as hybridization assays have been employed to determine DNA impurities, these methods are labor intensive and rather expensive. In this study, a rapid real-time PCR test was served as a method of choice to quantify the E. coli host- cell DNA contamination in widely used recombinant streptokinase (rSK) , and alpha interferon (IFN-α) preparations.

Methods

A specific primer pair was designed to amplify a sequence inside the E. coli 16S rRNA gene. Serial dilutions of DNA extracted from E. coli host cells, alo

SUBMITTER: Mamnoon B 

PROVIDER: S-EPMC4689282 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature